Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast 2014-2016 & 2018-2023 -

Research and Markets
Posted on: 09 Mar 18

The "Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast (2018-2023)" report has been added to's offering.

Global research antibodies and reagents market is expected to reach USD 13,276.5 million by 2023, at a CAGR of 6.5% during the forecast period of 2018 to 2023.

The report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Rising proteomics and genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are majorly driving the global research antibodies and reagents market. However, high cost and time related to development of potential antibodies hinders the growth of this market to some extent.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017).

Scope of the report

Market by Product:

  • Reagents
  • Media and Serum
  • Stains and Dyes
  • Probes
  • Buffers
  • Solvents
  • Enzymes
  • Proteins
  • Others

Research Antibodies Market, by Type

  • Primary Antibodies
  • Secondary Antibodies
  • ResearchAntibodies Market, by Production
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Antibodies Fragments

Research Antibodies Market, by Source

  • Mouse
  • Rabbit
  • Others

Research Antibodies Market, by Research Areas

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Immunology
  • Neurology
  • Stem Cell
  • Others

Market by Technology:

  • Western Blotting
  • Immunofluorescence
  • Immunosorbent Assays
  • Flow Cytometry
  • Immunohistochemistry
  • Immunoprecipitation
  • Others

Market by Application:

  • Proteomics
  • Drug Discovery & Development
  • Genomics

Market by End User:

  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Institutes
  • Contract Research Organizations

Companies Mentioned

  • GE Healthcare (U.S.)
  • Merck & Co. Inc.(U.S.)
  • Thermo Fisher Scientific Inc.(U.S.)
  • Amgen Inc.(U.S.)
  • Sanofi (France)
  • F. Hoffmann La-Roche Ltd (Switzerland)
  • Rockland Immunochemicals Inc.(U.S.)
  • Johnson & Johnson (U.S.)
  • Agilent Technologies Inc.(U.S.)
  • Eli Lilly and Company (U.S.)
  • Becton Dickinsonand Company (U.S.)
  • Danaher Corporation (U.S.)
  • PerkinElmer Inc.(U.S.)
  • GenScript Biotech Corporation (U.S.)
  • Lonza (Switzerland)
  • Bio-Techne Corporation (U.S.)
  • Bio-Rad Laboratories Inc.(U.S.)
  • Teva Pharmaceutical Industries Limited (Israel)
  • Santa Cruz Biotechnology Inc.(U.S.)
  • BioLegend Inc.(U.S.)
  • Abcam PLC (U.K.)
  • Cell Signaling Technology Inc.(U.S.)

For more information about this report visit

View source version on

Business Wire

Last updated on: 09/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.